Evaluation of tests for lyme disease [16]

Journal of Clinical Microbiology

Volumn 44, Issue 4, 2006, Pages 1616-

  Spinhirne, Joel ^a  

^a Verim Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

BORRELIA BURGDORFERI; HUMAN; LABORATORY TEST; LETTER; LYME DISEASE; MORBIDITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; SKIN;

HUMANS; IMMUNOENZYME TECHNIQUES; LYME DISEASE; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

BORRELIA BURGDORFERI;

EID: 33645945586     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.4.1616-1617.2006     Document Type: Letter

References (3)

1. Coulter, P., C. Lema, D. Flayhart, A. S. Linhardt, J. N. Aucott, P. G. Auwaerter, and J. S. Dumler. 2005. Two-year evaluation of Borrelia burgdorferi culture and supplemental tests for definitive diagnosis of Lyme disease. J. Clin. Microbiol. 43:5080-5084.
2. Oksi, J., M. Marjamaki, J. Nikoskelainen, and M. K. Viljanen. 1999. Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis. Ann. Med. 31:225-232.
3. Wormser, G. P., R. B. Nadelman, R. J. Dattwyler, D. T. Dennis, E. D. Shapiro, A. C. Steere, T. J. Rush, D. W. Rahn, P. K. Coyle, D. H. Persing, D. Fish, B. J. Luft, et al. 2000. Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin. Infect. Dis. 31(Suppl. 1):1-14.